XML 30 R5.htm IDEA: XBRL DOCUMENT v3.3.1.900
Consolidated Statements of Convertible Preferred Stock and Stockholders' (Deficit) Equity - USD ($)
$ in Thousands
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Total
Balance at Dec. 31, 2012 $ 3 $ 202,795 $ (87,136) $ 115,662
Balance (in shares) at Dec. 31, 2012 27,136,329      
Increase (Decrease) in Stockholders' Equity        
Issuance of common stock, net of issuance costs   91,312   91,312
Issuance of common stock, net of issuance costs (in shares) 5,428,000      
Issuance of common stock resulting from exercise of stock options   634   634
Issuance of common stock resulting from exercise of stock options (in shares) 162,480      
Issuance of common stock resulting from Employee Stock Purchase Plan   147   147
Issuance of common stock resulting from Employee Stock Purchase Plan (in shares) 7,831      
Issuance of common stock as payment of Board of Directors fees in lieu of cash   253   253
Issuance of common stock as payment of Board of Directors fees in lieu of cash (in shares) 4,368      
Stock-based compensation expense   7,506   7,506
Net Income (Loss) Available to Common Stockholders, Basic     (92,362) (92,362)
Balance at Dec. 31, 2013 $ 3 302,647 (179,498) 123,152
Balance (in shares) at Dec. 31, 2013 32,739,008      
Increase (Decrease) in Stockholders' Equity        
Issuance of common stock, net of issuance costs $ 1 94,198   94,199
Issuance of common stock, net of issuance costs (in shares) 3,200,000      
Issuance of common stock resulting from exercise of stock options   1,630   1,630
Issuance of common stock resulting from exercise of stock options (in shares) 159,747      
Issuance of common stock resulting from Employee Stock Purchase Plan   249   249
Issuance of common stock resulting from Employee Stock Purchase Plan (in shares) 9,845      
Cancellation of unvested restricted stock (8,929)      
Issuance of common stock as payment of Board of Directors fees in lieu of cash   274   274
Issuance of common stock as payment of Board of Directors fees in lieu of cash (in shares) 10,411      
Conversion option of convertible notes - net of issuance costs   84,984   84,984
Capped call options associated with convertible notes   (20,829)   (20,829)
Stock-based compensation expense   11,409   11,409
Net Income (Loss) Available to Common Stockholders, Basic     (171,012) (171,012)
Balance at Dec. 31, 2014 $ 4 474,562 (350,510) $ 124,056
Balance (in shares) at Dec. 31, 2014 36,110,082     36,110,082
Increase (Decrease) in Stockholders' Equity        
Issuance of common stock, net of issuance costs   179,753   $ 179,753
Issuance of common stock, net of issuance costs (in shares) 3,755,000      
Issuance of common stock resulting from exercise of stock options   7,930   7,930
Issuance of common stock resulting from exercise of stock options (in shares) 382,580      
Issuance of common stock resulting from Employee Stock Purchase Plan   830   830
Issuance of common stock resulting from Employee Stock Purchase Plan (in shares) 20,601      
Issuance of common stock resulting from the vesting of restricted stock units, net of shares withheld for taxes   (201)   (201)
Issuance of common stock resulting from the vesting of restricted stock units, net of shares withheld for taxes (in shares) 8,091      
Issuance of common stock as payment of Board of Directors fees in lieu of cash   266   266
Issuance of common stock as payment of Board of Directors fees in lieu of cash (in shares) 3,429      
Stock-based compensation expense   25,648   25,648
Net Income (Loss) Available to Common Stockholders, Basic     (251,408) (251,408)
Balance at Dec. 31, 2015 $ 4 $ 688,788 $ (601,918) $ 86,874
Balance (in shares) at Dec. 31, 2015 40,279,783     40,279,783